Comparative incidence of endophthalmitis after intravitreal dexamethasone implant versus anti-VEGF injections: a retrospective study [PDF]
International Journal of Retina and VitreousBackground Endophthalmitis is a rare but vision-threatening complication of intravitreal injections. Intravitreal dexamethasone implants and anti–vascular endothelial growth factor (anti-VEGF) agents are widely used, yet comparative real-world ...
Iza D. Zabaneh +3 more
doaj +2 more sources
Complications of Dexamethasone Implants: Risk Factors, Prevention, and Clinical Management [PDF]
International Journal of Ophthalmology, 2020 AIM: To evaluate major complications after intravitreal injection of dexamethasone implants (Ozurdex) and their clinical management. METHODS: In a retrospective observational study between 2014 and 2016 at two university hospitals, we reviewed the ...
Ramin Khoramnia +2 more
exaly +2 more sources
Dexamethasone Intravitreal Implant in Cystoid Macular Edema Secondary to Paclitaxel Therapy
American Journal of Ophthalmology Case Reports, 2020 Purpose: To report the first case of cystoid macular edema (CME) induced by nabpaclitaxel treated with intravitreal dexamethasone implant. Observations: A 67 year-old man diagnosed with unresectable pancreatic cancer presented with decreased vision in ...
Lorenzo López-Guajardo +2 more
exaly +3 more sources
Subconjunctival dexamethasone implant (Ozurdex) for peripheral ulcerative keratitis [PDF]
American Journal of Ophthalmology Case ReportsPurpose: To report a case of peripheral ulcerative keratitis (PUK) successfully treated with subconjunctival dexamethasone implant (Ozurdex®) injection. Observations: An 82-year-old female presented with PUK in the right eye.
Hashem H. Ghoraba +6 more
doaj +2 more sources
A case of accidental into-the-lens dexamethasone implant: watching or removing? [PDF]
BMC OphthalmologyBackground To report a case of cataract surgery in unintentional Ozurdex (Allergan, Inc., Irvine, California, USA) injection into the lens. Case presentation A 82-years old man reporting decreased visual acuity in his right eye came to our Ophthalmology ...
Maria Ludovica Ruggeri +4 more
doaj +2 more sources
Comparison of intravitreal aflibercept and dexamethasone implant in the treatment of macular edema associated with diabetic retinopathy or retinal vein occlusion: a Meta-analysis and systematic review [PDF]
International Journal of Ophthalmology, 2022 AIM: To compare the efficacy and safety of intravitreal aflibercept with dexamethasone implant in the treatment of macular edema (ME) associated with diabetic retinopathy (DR) or retinal vein occlusion (RVO).
Xuan-Yu Qiu +6 more
doaj +1 more source
Comparison of Dexamethasone Implant and Anti-VEGF Agents in the Treatment of Naive Diabetic Macular Oedema: A Prospective Cohort Study [PDF]
Journal of Clinical and Diagnostic Research, 2023 Introduction: Diabetic Retinopathy (DR) is one of the common microvascular complications of diabetes. In patients with DR, the most frequent cause of vision loss is Diabetic Macular oedema (DME).
Vanaja Iyer +4 more
doaj +1 more source
Revista Brasileira de Oftalmologia, 2021 This report aims to describe the effectiveness of a unilateral intravitreal dexamethasone implant (Ozurdex®) used for the treatment of cystoid macular edema in a patient with recurrent intermediate uveitis.
Bruno Boalento dos Santos +3 more
doaj +1 more source
A case of bilateral cystoid macular edema after rituximab infusion
Indian Journal of Ophthalmology. Case Reports, 2022 A 65-year-old man experienced sudden bilateral vision loss after rituximab infusion. Best corrected visual acuity was 1/10, and cystoid macular edema was identified.
Alexandros Rouvas +2 more
doaj +1 more source
Oman Journal of Ophthalmology, 2020 We report a case of refractory secondary ocular hypertension after insertion of dexamethasone implant (OZURDEX) for posterior uveitis in a young patient, which necessitated removal of the implant through pars plana vitrectomy along with a trabeculectomy.
Rathini Lilian David, Parveen Sen
doaj +1 more source